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The Swiss Centre for Antibiotic Resistance (ANRESIS) has recently noted an increase of 27 
extended-spectrum cephalosporin-resistant (ESC-R) S. sonnei isolates nationwide (3.8% in 28 
2016 vs. 37.5% in 2019). To understand this phenomenon, we analyzed 25 representative 29 
isolates (of which 14 ESC-R) collected in Switzerland during 2016-2019. Whole-genome 30 
sequencing was achieved using both Illumina and Nanopore platforms. Both ESC-R and 31 
susceptible isolates belonged to ST152. The ESC-R isolates carried blaCTX-M-3 in IncI1-pST57 32 
(n=5), blaCTX-M-15 in IncFII (F2:A-:B-) (n=5), blaCTX-M-15 in IncI1-pST16, and blaCTX-M-27, 33 
blaCTX-M-55, or blaCTX-M-134 in other IncFII plasmids (n=1 each). Plasmids having the same bla 34 
and Inc group exhibited high genetic identity to each other, but also to plasmids previously 35 
reported in other Enterobacterales. Core-genome analysis showed that there were 4 main 36 
clusters, each of which included strains that differed by <58 SNVs, both blaCTX-M-positive and 37 
blaCTX-M-negative isolates. Moreover, most isolates belonging to the same cluster shared an 38 
identical cgST. For instance, cluster-1 included 4 isolates of cgST113036, of which only 3 39 
harbored the IncI1-pST57 blaCTX-M-3-positive plasmid. The 25 S. sonnei isolates were also 40 
subjected to phylogenetic comparison with deposited international strains. As a result, 41 
matching isolates (same cgST and differing by <8 SNVs) have been reported in the UK, USA, 42 
France, and the Netherlands. Overall, our results suggest that some common S. sonnei clusters 43 
can spread between continents and can be imported into other nations after international trips. 44 
Such clusters include, in part, isolates that do not possess blaESBL-harboring plasmids, 45 




Shigella flexneri is one of the most common causes of diarrhea in low-/middle-income 48 
countries and is associated with high morbidity and mortality rates. In contrast, Shigella 49 
sonnei is the leading species in high-income nations with the majority of cases described in 50 
returning travelers, men who have sex with men (MSM), and young children (1-3). 51 
The emergence of antibiotic-resistant S. sonnei isolates is nowadays a matter of concern 52 
(4). The high resistance rates to first-line options (e.g., ciprofloxacin and azithromycin) have 53 
made ceftriaxone the drug of choice for empirical treatment. However, there has also been a 54 
significant recent increase in extended-spectrum cephalosporin-resistant (ESC-R) isolates, 55 
especially in Asia (1, 5). 56 
Usually, ESC-R S. sonnei (ESC-R-Ss) isolates produce extended-spectrum β-lactamases 57 
(ESBL) of the CTX-M-type, of which CTX-M-3, CTX-M-14, CTX-M-15, CTX-M-27, and 58 
CTX-M-55 are the most common (6). However, only a few studies have implemented whole-59 
genome sequencing (WGS) to characterize the blaCTX-M-carrying plasmids in detail. So far, a 60 
blaCTX-M-3- IncI1 from Italy (7), a blaCTX-M-14- IncB/O/K/Z from China (8), a blaCTX-M-15- IncI1 61 
from South Korea (9), a blaCTX-M-27- IncFII from the UK (10), and a blaCTX-M-55-harboring 62 
IncI2 plasmid from China have been described in S. sonnei (11). For Switzerland, we note 63 
that the first two ESC-R-Ss strains (CTX-M-14 and CTX-M-15 producers) were isolated in 64 
2009, but no WGS analyses were performed on the 8 strains detected during 2009-2014 (12). 65 
Due to the ability of S. sonnei to acquire multidrug-resistant (MDR) plasmids and the fact 66 
that it shows a higher prevalence in industrialized countries compared to S. flexneri (3), 67 
attention needs to be focused on the clonality of ESC-R-Ss. Just recently (2018), in the 68 
European Union, 17 outbreaks due to S. sonnei have been documented (13).  69 
Several authors have implemented the multilocus sequence typing (MLST), which has 70 
revealed that sequence type (ST) 152 is the most frequent lineage among ESC-susceptible S. 71 
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sonnei (ESC-S-Ss) isolates (14-19). Other recent studies have also used core-genome analyses 72 
to investigate epidemiological events (2, 15, 20, 21), although only one UK survey analyzed 73 
exclusively ESBL-producing S. sonnei strains (10). Overall, these studies have shown that 74 
single nucleotide variant (SNV) analysis represents a high-resolution tool for determining 75 
clonality and tracking outbreaks at the community and global levels.  76 
In this study, therefore, we used WGS to characterize the plasmids of ESC-R-Ss isolates 77 
detected in Switzerland. Moreover, to investigate the hidden epidemiological profile of 78 
contemporary circulating isolates, we implemented a core-genome analysis to determine the 79 
clonality of ESC-R- and ESC-S-Ss strains.  80 
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RESULTS AND DISCUSSION 81 
Rate of ESC-R-Ss and analyzed strains. According to the ANRESIS database, 53, 39, 85, 82 
and 56 S. sonnei isolates were identified nationwide in 2016, 2017, 2018 and 2019 by 83 
participating laboratories, respectively. Of them, 2 (3.8%), 5 (12.8%), 12 (14.1%) and 21 84 
(37.5%) were reported as ESC-R, respectively.  85 
Unfortunately, such results could not be compared to those of other countries. In fact, 86 
though the spread of ESC-R Shigella spp. is of concern, recent studies analyzing their trends 87 
are lacking (1, 4). Nevertheless, we note that in China the rate of ESC-R-Ss increased from 88 
31.6% in 2012 to 64.3% in 2015 (22), whereas lower rates were recorded in other nations 89 
during point-prevalence surveys (e.g., in 2015, 12% in England/Wales and 0% in Nepal; in 90 
2015-2016, 7.1% in New Zealand) (10, 23, 24). It is therefore difficult to interpret our data on 91 
the persistent increase in resistance to ESCs. In this context, we emphasize that the Swiss 92 
population is at greater risk of acquiring and importing MDR Shigella spp. from endemic 93 
areas due to its high propensity for international travel (12, 25). For this reason, in order to 94 
better understand this general epidemiological phenomenon, a molecular characterization of 95 
the strains is essential.  96 
In the present study, we analyzed 14 ESC-R-Ss and 11 ESC-S-Ss collected in Switzerland 97 
during 2016-2019. Species identification (ID) and antibiotic resistance phenotypes of all 98 
strains were confirmed by appropriate methods before further molecular analyses (see 99 
Material and Methods section and Tab. S1). 100 
Antimicrobial resistance genes (ARGs). As shown in Tab. 1, both ESC-R- and ESC-S-Ss 101 
isolates carried numerous ARGs conferring resistance to different classes of antibiotics, 102 
including quinolones (e.g., qnrS1) and macrolides [e.g., erm(B) and mph(A)] (6). Those 103 
phenotypically resistant to ESCs mainly possessed blaCTX-M-3 (n=5) or blaCTX-M-15 (n=6) ESBL 104 
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genes, but unique isolates harboring blaCTX-M-27, blaCTX-M-55 and blaCTX-M-134 were also 105 
detected. 106 
Although studies analyzing the prevalence of specific blaESBLs in S. sonnei are lacking, blaCTX-107 
M-15 and blaCTX-M-3 appear to be the most frequent worldwide (6). In particular, CTX-M-3 108 
producers were described in Turkey, Switzerland and Italy (7, 12, 26, 27), while those with 109 
CTX-M-15 have been found in various countries, including South Korea, where an outbreak 110 
was described (9). With regard to the other ESBLs, a CTX-M-27-producing S. sonnei clone 111 
was responsible for an outbreak in 2015 among MSM in England (10), CTX-M-55 was 112 
reported in S. sonnei isolates from China and South Korea (11, 28), while CTX-M-134 was 113 
only recently described in E. coli (29).               114 
Since blaCTX-Ms are usually carried by plasmids that can be exchanged between different 115 
species of enterobacteria (e.g., from E. coli to S. sonnei in the human gut) (30), their 116 
characterization is crucial for understanding the expansion of ESC-R-Ss isolates.  117 
IncI1 blaCTX-M-3-carrying plasmids. As shown in Fig. 1A, 5 S. sonnei isolates harbored 86-118 
87kb IncI1-pST57 blaCTX-M-3 carrying plasmids with a high genetic identity to each other and 119 
to the Italian pLC1477_18_1 that we recently described (conjugation frequency, 1.2 x 10
-4
) 120 
(7).  121 
In all of these plasmids, blaCTX-M-3 was associated with a truncated ISEcp1 in the same 122 
element reported in the Italian plasmid. Considering the strong genetic similarity of the five 123 
IncI1-pST57 blaCTX-M-3 carrying plasmids collected in Switzerland, it is quite possible that 124 
other plasmids with similar genetic characteristics exist outside the country. For instance, an 125 
Enterobase S. sonnei strain from the UK in 2019 (named 811053; BioSample: 126 
SAMN12881824) of the same cgST as our 509-1022 and 19-0822-3296 isolates 127 
(cgST115537) was found to harbor blaCTX-M-3 and contained at least one pST57 plasmid (CGE 128 
analysis; data not shown). Similarly, an E. coli strain from a 2013-2015 study in the 129 
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Netherlands was reported to be carrying an IncI1-pST57 plasmid that possessed blaCTX-M-3 130 
(31).  131 
IncFII blaCTX-M-15-harboring plasmids. As depicted in Fig. 1B, 5 other ESC-R-Ss harbored 132 
IncFII (F2:A-:B-) blaCTX-M-15-carrying plasmids (83-89kb) with high genetic identity to each 133 
other and to pF93-2_1 (GenBank: CP026158) from K. pneumoniae found in China in 2014. 134 
Globally, the F2: A-: B- is the predominant F plasmid type carrying blaCTX-Ms among 135 
Enterobacteriaceae and is highly conjugative (32).     136 
The 5 blaCTX-M-15-carrying plasmids identified in the present work shared an identical genetic 137 
environment around blaCTX-M-15, including both full (IS26 and ISKpn19) and partial (ΔTn3 138 
and ΔIS3) transposable element coding sequences (CDS), along with the qnrS1 (Fig. 1B). The 139 
plasmid p19-0820-1561 also contained additional ARGs [mph(A), sul1, aadA5, and dfrA17] 140 
that were only present in pF93-2_1 in the form of the IS26-mph(A)-MFS transporter-141 
tetR/acrR-IS6100-sul1-aadA5-dfrA17-intl1Δ-IS26-Tn3Δ-IS1RΔ unit. This element has been 142 
reported in multiple species such as E. coli and K. pneumoniae (BLAST analysis; data not 143 
shown).  144 
Other blaCTX-M-carrying plasmids. The remaining 4 ESC-R-Ss isolates possessed unique 145 
blaCTX-M-positive plasmids (Tab. 1). In particular, a blaCTX-M-15 associated with ISEcp1 was 146 
carried in an 89kb IncI1-pST16 plasmid (p6607-69), but without further ARGs. This plasmid 147 
showed a high identity with others found in both S. sonnei and E. coli isolates (mostly from 148 
Asia), including some expressing the CTX-M-55 that is a single amino acid variant of CTX-149 
M-15 (Fig. S1). Likewise, one of our S. sonnei isolates carried the blaCTX-M-55, but in this case 150 
the gene was located in a 74kb IncFII (F2:A-:B-) plasmid (p0401952027) and was flanked by 151 
two IS26. This plasmid showed a high genetic identity with others possessing blaCTX-M-55 or 152 
blaCTX-M-15 that came from E. coli or K. pneumoniae isolates detected in Europe or North 153 
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America, but, interestingly, none of them co-carried the tetR/acrR-MFS trans-mph(A) unit 154 
between IS6100 and IS1RΔ (Fig. S2).      155 
Another ESC-R-Ss carried a 67kb IncFII (F2:A-:B-) plasmid (p09163633) that harbored 156 
only blaCTX-M-27 and showed a high identity with the backbone of plasmids from E. coli and S. 157 
flexneri isolates. Nevertheless, only p09163633 possessed the IS26-IS903BΔ-blaCTX-M-27-158 
ISEcp1Δ-IS26 unit (Fig. S3), which has been reported in multiple E. coli and K. pneumoniae 159 
isolates from Vietnam and China (BLAST analysis; data not shown), and also described in a 160 
Japanese epidemic ST131 E. coli (33). Moreover, it was also present in the 69kb IncFII 161 
(F35:A-:B-) plasmid (p3123885) found in our last ESC-R-Ss (Fig. S4), though this mobile-162 
genetic element (MGE) encoded the single amino acid variant CTX-M-134 instead of the 163 
CTX-M-27 (29).  164 
Co-resistance to azithromycin. Besides the specific ESBLs identified, 6 of the 25 S. sonnei 165 
isolates were macrolide-resistant due to the presence of erm(B) and/or mph(A) ARGs (Tab. 1 166 
and Tab. S1). As mentioned above, 3 ESC-R isolates carried mph(A) in different IncFII 167 
plasmids co-harboring blaCTX-M-15, blaCTX-M-55, or blaCTX-M-134. Of note, two of these plasmids 168 
carried the element IS26-mph(A)-MFS trans- tetR/acrR-IS6100 (Fig. 1B and S4) and the other 169 
one carried, with a slightly different arrangement, IS6100-tetR/acrR-MFS trans-mph(A)-170 
IS1RΔ (Fig. S2). These two very similar elements have been found in many plasmids carried 171 
by E. coli, K. pneumoniae, Salmonella enterica (BLAST analysis; data not shown), and also 172 
identified in the chromosome of a CTX-M-15-producing Salmonella Haardt isolated from 173 
Japanese food workers (34). 174 
Overall, these findings are epidemiologically relevant, since co-resistance to 175 
azithromycin and ESCs makes the treatment of shigellosis difficult (1, 5). Such MDR 176 
plasmids have been rarely reported in S. sonnei, though an IncFII (F2:A-:B-) plasmid 177 
possessing blaCTX-M-27, mph(A), and erm(B) was associated with the outbreak among MSM in 178 
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England (10), while an IncB/O/K/Z co-harboring blaCTX-M-14 and mph(A) was linked to a 179 
waterborne outbreak in China in 2015 (8). Having observed that at least three of our IncFII 180 
plasmids carried very similar macrolide resistance elements, we speculate that under a certain 181 
antibiotic selective pressure (e.g., azithromycin), mph(A) can be acquired via integration of 182 
transposable elements (e.g., IS26-mph(A)-MFS trans- tetR/acrR-IS6100) (35).         183 
MLST and cgMLST. Regardless of the presence of blaCTX-M genes, 24 S. sonnei isolates were 184 
of ST152, while one was of its single allele variant ST1503 (Tab. 1). ST152 has been 185 
previously reported in ESC-S-Ss in many countries (e.g., California, China, Germany and 186 
Iran) (15-19). Recently, we also described the ST152 CTX-M-3-producing strain LC-1477-18 187 
isolated in Italy from a girl who acquired the infection in Albania (7). Overall, since our S. 188 
sonnei isolates were acquired in different periods and/or in diverse geographic areas (Tab. 1), 189 
one could speculate that a unique clone (ST152) is spreading worldwide. 190 
To better investigate the clonality of our S. sonnei isolates, we performed a cgMLST 191 
analysis according to the E. coli scheme. The higher resolution of cgMLST resulted in 192 
multiple cgSTs:  i) three blaCTX-M-3-possessing isolates and one ESC-S of cgST113036; ii) two 193 
blaCTX-M-3-positives of cgST115537; iii) four blaCTX-M-15-harboring of cgST112958; and iv) 194 
two ESC-S isolates carrying mph(A) and erm(B) were of cgST107674. The remaining isolates 195 
showed different cgSTs, but overall maintaining high allele matches among the 2513 196 
analyzed (i.e., >98.5% for ESBL producers and >98.6% for those ESC-S) (Tab. 1). These 197 
results support the hypothesis that common ESC-R clones may spread in different countries 198 
and could be imported to other nations (e.g., Switzerland) after international trips. Based on 199 
the identification of clones including both ESBL producers and not producers, it can be also 200 
speculated that some ESC-S-Ss may be well-predisposed to acquire MDR plasmids from 201 
other Enterobacterales.     202 
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Core-genome analyses. To determine the distance and clonality between our S. sonnei strains, 203 
a high-resolution SNV analysis was performed (87% core-genome coverage among all 204 
strains). As shown in Fig. 2, the 4 S. sonnei clones identified by cgMLST were also confirmed 205 
as 4 independent SNV clusters, though several additional isolates were grouped within 206 
cluster-2 and cluster-4. To summarize: cluster-1 and cluster-2 included CTX-M-3-producing 207 
or ESC-S-Ss; cluster-3 encompassed CTX-M-15 producers; and cluster-4 included the CTX-208 
M-134 producer and ESC-S-Ss. Notably, strains belonging to the same cluster differed by 209 
only a limited number of SNVs (i.e., cluster-1: ∆=7-26 SNVs; cluster-2: ∆=12-34 SNVs; 210 
cluster-3: ∆=5-19 SNVs; and cluster-4: ∆=2-58 SNVs). 211 
Together, these results corroborate the above hypothesis on the dissemination of CTX-M-212 
producing hyperepidemic S. sonnei clones. This is consistent with what has been observed by 213 
other authors for the fluoroquinolone-resistant international clones (e.g., the global lineage III, 214 
GIII) (36, 37). However, our data also indicate that MLST analysis alone has a limited 215 
resolution for studying the spread of such MDR pathogens. In fact, although almost all of our 216 
S. sonnei isolates were identified as ST152, several clusters with different ARG and plasmid 217 
patterns could be differentiated using cgMLST and/or core-genome SNV analyses. 218 
We also note that isolates included in cluster-1 and cluster-2 carried the same IncI1-219 
pST57 blaCTX-M-3 plasmid (Fig. 1). This finding was surprising, as the two bacterial groups 220 
were genetically different (i.e., Δ=235 SNVs; Fig. 2). We do not have a clear explanation for 221 
the independent clustering, but it can be hypothesized that ESC-S S. sonnei isolates belonging 222 
to cluster-1 and cluster-2 acquired the pST57 plasmid from a common enterobacterial 223 
ancestor, including other Shigella spp.  224 
Link with international isolates. To explore the lineage origins of our Swiss S. sonnei 225 
isolates, we performed a database search in Enterobase for strains of global lineage and 226 
matching cgST. A core-genome analysis was then performed using the results of the 227 
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Enterobase phylogenetic analysis as reference. Overall, we compared our collection (n=25) to 228 
a subset of 114 strains of global lineage (38), 16 of matching cgST, and the Italian LC-1477-229 
18 isolate (7). The alignment of all strains (n=156) resulted in 4551 SNVs and 42% core-230 
genome coverage among all isolates. 231 
As depicted in Fig. 3 and Tab. S2, all S. sonnei isolates included in cluster-1 were related 232 
to an Iranian GIII strain detected in 2003, and were almost identical to another one found in 233 
the UK in 2016 (same cgST and Δ=2-3 SNVs). We also note that one of our isolates (7111-234 
69) had its clinical origin in Turkey (Tab. 1), the area where the first CTX-M-3-producing S. 235 
sonnei was described (2001) and subsequently caused epidemic events (26, 27).  236 
The cluster-2 and cluster-3 isolates were part of a large group shared by two GIII strains 237 
of Egyptian origin reported in 2005-2006, LC-1477-18, and four detected in the UK: one 238 
CTX-M-3 producer isolated in 2019, two CTX-M-15 producers detected in 2015-2016, and 239 
one ESC-S found in 2015 (Fig. 3). These UK strains showed ≤5 Δ SNVs when compared to 240 
cgST- matching  isolates from Switzerland, indicating their commonality. Further evidence of 241 
their possible origin could be seen in isolates 6105-15, 0401930105, 19-0821-3486, and 242 
0401952027 where Egypt was their origin (Tab. 1), suggesting that these strains may have 243 
originated in that geographic area.  244 
S. sonnei cluster-4 isolates were grouped with recently detected ESC-S strains in the UK, 245 
the USA, and France. Two additional CTX-M-15 producers, one from the UK (821179) and 246 
one from the Netherlands (IBESS820), were also highly related with the cluster-4 isolates 247 
(Fig. 3). The latter was identified in 2017 during a cross-sectional multicenter study (39), and 248 
was genetically identical to our ESC-S-Ss 6412-75 strain (same cgST and Δ=0 SNPs). In that 249 
study, the patient of strain IBESS820 was reported to have a history of travel to India, as was 250 
the Swiss patient with an infection caused by 6412-75 (Tab. 1). Despite these similarities, the 251 
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Swiss S. sonnei was ESBL-negative; nevertheless, this finding highlights the great capacity of 252 
certain clones to acquire blaCTX-M-harboring plasmids.    253 
 In total, 12 of the 16 international S. sonnei strains that have the same cgST as our 254 
Swiss isolates were detected in the UK, while the remaining 4 were isolated in the USA, 255 
France, and the Netherlands. This indicates that common S. sonnei lineages have been 256 
circulating in Europe at least since 2015, and are now expanding in Switzerland. In fact, we 257 
note that all 10 Swiss ESC-R-Ss detected in 2019 were linked to isolates detected in the same 258 
year in the UK and France (Tab. 1 and Fig. 3), most of which were producers of CTX-M-3 or 259 
CTX-M-15, as in the case of those in Switzerland.  260 
It can be speculated that the same common plasmids described in the present work (e.g., the 261 
IncI1-pST57 blaCTX-M-3-positive) are also carried by contemporary non-Swiss ESC-R-Ss 262 
isolates (as demonstrated for LC-1477-18). However, since the matching cgST isolates 263 
identified from the Enterobase database are in the form of whole genome shotgun assemblies 264 
generated from short-read data, without the full characterization of blaCTX-M-carrying 265 
plasmids with long-read sequencing data as in our study, this hypothesis cannot be fully 266 
corroborated. 267 
Conclusions. In this work, we presented the first detailed molecular investigation of S. sonnei 268 
isolates detected in Switzerland. Hybrid WGS assemblies were implemented to accurately 269 
describe the blaCTX-M-harboring plasmids, while core-genome and phylogenetic analyses were 270 
used to study the clonality of the strains.  271 
Based on our results, we conclude that most of the contemporary Swiss ESBL-producing 272 
S. sonnei isolates carry identical blaCTX-M-positive plasmids that often have their counterparts 273 
in other reported Enterobacterales worldwide. More importantly, due to transnational travel, 274 
common international clones of MDR S. sonnei are emerging in Switzerland and this limits 275 
our therapeutic armamentarium. Overall, our findings underline the importance of 276 
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continuously conducting epidemiological surveys using the WGS approach and linking the 277 
results with other countries (40).   278 
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MATERIALS AND METHODS 279 
Epidemiological data. Phenotypic data regarding the S. sonnei isolates detected in 280 
Switzerland during 2016-2019 were retrieved from the Swiss Centre for Antibiotic Resistance 281 
(ANRESIS) database (http://www.anresis.ch/) that collects information from 30 Swiss clinical 282 
laboratories. Strains were categorized as ESC-R when non-susceptible (i.e., intermediate or 283 
resistant) to ceftazidime, ceftriaxone, and/or cefepime according to the criteria implemented 284 
for Enterobacterales by the routine clinical laboratories during the corresponding years. The 285 
research project was exempted from the requirement for ethical approval because no health-286 
related personal data were used, while age, gender, and trip-related information (if available) 287 
were retrieved from the laboratory databases.       288 
Strains, ID and antimicrobial susceptibility tests. All ESC-R- and ESC-S-Ss isolates 289 
available at -80°C and collected during 2016-2019 at the Institute for Infectious Diseases, 290 
MCL Medizinische Laboratorien, and labormedizinisches zentrum Dr. Risch were analyzed. 291 
The initial ID obtained by implementing the MALDI-TOF MS (Bruker) was confirmed with 292 
the Type Strain Genome Server (TYGS) tools using Genome BLAST Distance Phylogeny 293 
(https://tygs.dsmz.de/) based on genome data (see below). MICs were obtained by 294 
implementing the Sensititre GNX2F microdilution panels (ThermoFisher). For isolates 295 
possessing erm(B) and/or mph(A) genes, MICs for azithromycin were obtained using the Etest 296 
(bioMérieux). Results were interpreted according to the EUCAST 2019 criteria (41).  297 
Whole-genome sequencing (WGS). WGS was performed using both NovaSeq-6000 298 
(Illumina) and MinION (Oxford Nanopore) sequencing platforms as previously described 299 
(42-45). In brief, Illumina raw reads were quality-filtered with Trimmomatic (v0.36), 300 
followed by whole-genome shotgun assembly with SPAdes (v3.12.0). Adaptors from 301 
Nanopore raw reads were trimmed with Porechop (v0.2.4), and quality filtered with Filtlong 302 
(v0.2.0). Long-read assemblies were done with Canu (v1.7). The final hybrid assemblies were 303 
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generated by aligning the paired-end Illumina reads to the Canu assemblies with Bowtie2 304 
(v2.3.4.1), and followed by multiple rounds of polishing with Pilon (v1.22).  305 
Illumina SPAdes assemblies were used for: whole genome ID, analysis with the tools of the 306 
Center for Genomic Epidemiology (CGE; http://www.genomicepidemiology.org/): 307 
ResFinder, MLST with the E. coli scheme #1, PlasmidFinder, and pMLST. Hybrid assemblies 308 
were used to characterize the blaESBL-carrying plasmids.   309 
Annotations of both Illumina and hybrid assemblies were carried out by the NCBI 310 
Prokaryotic Genome Annotation Pipeline. All annotated features presented in Fig. 1 and Fig. 311 
S1-S4 were manually curated with UniProt (https://www.uniprot.org/blast/) and ISfinder 312 
(https://isfinder.biotoul.fr/), and annotated accordingly.  313 
Core-genome analyses. All S. sonnei isolates underwent cgMLST with CGE cgMLSTFinder 314 
(v1.1) using Illumina raw reads as input and species' database set to E. coli Enterobase. These 315 
isolates also undertook core-genome SNV analysis as previously done (46). Briefly, the core-316 
genome alignment was performed with Parsnp v1.2. All strains were treated as curated 317 
genomes (-c parameter), and the Italian ST152 CTX-M-3-producing S. sonnei strain (LC-318 
1477-18; GenBank: JAATWD000000000) was used as reference (7). The –C parameter was 319 
set to 200, and other parameters were let as default. Variants with no flags (PASS) were 320 
determined as reliable, and used for downstream SNV analysis with a custom R (v3.6.2) 321 
script. The Parsnp-generated core-genome SNV phylogenetic tree was visualized with 322 
FigTree (v1.4.4), and set to midpoint-rooted, and nodes by decreasing order (Fig. 2). 323 
A SNV tree dendrogram of the Swiss S. sonnei collection vs. global lineage and 324 
matching cgST strains was created in the Enterobase Escherichia/Shigella database 325 
(https://enterobase.warwick.ac.uk/species/index/ecoli) (Fig. 3). The analyzed strains consisted 326 
of 156 total strains of which 114 were of global lineage (38), 16 of matching cgST, 25 from 327 
Switzerland, and the Italian LC-1477-18 as reference. The following search queries were used 328 
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to find the global lineage strains (date: April 10, 2020) in Enterobase: Species equals 329 
"Shigella sonnei"; Comment contains "Holt Lineage“; and to find matching cgST strains 330 
(date: April 21, 2020) : Experiment type= cgMLST V1 + HierCC V1; ST=108909, 108083, 331 
64457, 108763, 117387, 101592, 108068, 114011, 107674, 113036, 67380, 109254, 98334, 332 
20888, 37499, 118753, 115537, 112958. The Illumina raw reads of our 25 S. sonnei isolates 333 
were uploaded to Enterobase for processing. The resulting assembled genomes by Enterobase 334 
were used to create a SNV project of 156 strains with default settings (min % sites present: 335 
95). The tree was visualized with the web-based browser.  336 
An independent core genome analysis (Tab. S2) with Parsnp was used to analyze the strain 337 
clusters identified in Fig. 3, which also included the 156 S. sonnei assemblies. As described 338 
above, the Italian LC-1477-18 was used as reference genome, the Parsnp -C parameter was 339 
set to 300, and the rest as default. 340 
Data availability. Illumina SPAdes assemblies were deposited under BioProject number 341 
PRJNA578838. Hybrid assemblies (blaESBL-carrying plasmids and corresponding 342 
chromosomes) were deposited under BioProject number PRJNA578858. 343 
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Table 1. S. sonnei strains analyzed in the present study: summary of the demographic and travel-related (if any) data along with the results for the whole-genome sequencing (WGS) analyses 518 
Note. M, male; F, female; ESC-R, extended-spectrum cephalosporin-resistant; ESC-S, ESC-susceptible; SXT, trimethoprim-sulfamethoxazole; CIP, ciprofloxacin; AZT, azithromycin; ST, sequence type; cgST, core-genome sequence type; na, not available   519 
a Based on the information provided to the clinical laboratory analyzing routine samples. Age has been approximated at ±5 years. The origin of infection has been attributed to a foreign country if symptoms (i.e., diarrhea) occurred during or after returning from a specific country) 520 
b Based on the MICs obtained with the Sensititre GNX2F panel and interpreted according to the EUCAST 2019 criteria. Only key antibiotics showing non-susceptibility have been reported in the "co-resistance" column (see Tab. S1 for full MIC results) 521 
c Performed implementing the tools of the Center for Genomic Epidemiology (CGE). Specifically, MLST (v2.0; E. coli #1 configuration), ResFinder (v3.2), PlasmidFinder (v2.0), and pMLST (v2.0) when available. In bold the main bla genes and their associated carrying plasmids  522 
d Core-genome results obtained with cgMLSTFinder (v1.1) 523 









Co-resistance b ST c Antimicrobial resistance genes / plasmid replicons (pMLST, approximated size) c 
Called alleles 
(%) among a 
total of 2513 d 
Allele 
matches in 
cgST (%) d 
cgST d 
L4094 2018 na/na na na ESC-R - ST152 blaCTX-M-3, aadA1, mdf(A), dfrA1 / l1 (pST57, 86kb), Col156, Col(BS512) 2503 (99.60) 2496 (99.32) cgST113036 
1205-3131 2018 35/M Stool Unknown ESC-R - ST152 blaCTX-M-3, aadA1, mdf(A), dfrA1 / l1 (pST57, 86kb), Col156, Col(BS512) 2500 (99.48) 2492 (99.16) cgST113036 
7111-69 2019 20/M Stool Turkey ESC-R - ST152 blaCTX-M-3, aadA1, mdf(A), dfrA1 / l1 (pST57, 86kb), Col156, Col(BS512) 2499 (99.44) 2491 (99.12) cgST113036 
LC-1477-18 e 2018 10/F Stool Albania ESC-R SXT ST152 blaCTX-M-3, aadA1, aph(3'')-Ib, aph(6)-Id, mdf(A), dfrA1, sul2, tet(A) / I1 (pST57, 85kb), Col156, Col(BS512) 2505 (99.68) 2498 (99.40) cgST118753 
509-1022 2019 50/F Stool Unknown ESC-R SXT ST152 blaCTX-M-3, aadA1, aph(3")-lb, aph(6)-ld, mdf(A), dfrA1, sul2, tet(A) / l1 (pST57, 88kb), Col156, Col(BS512)  2503 (99.60) 2495 (99.28) cgST115537 
19-0822-3296 2019 5/F Stool Unknown ESC-R SXT ST152 blaCTX-M-3, aadA1, aph(3")-lb, aph(6)-ld, mdf(A), dfrA1, sul2, tet(A) / l1 (pST57, 88kb), Col156, Col(BS512) 2504 (99.64) 2495 (99.28) cgST115537 
6607-69 2017 60/F Stool Sri Lanka ESC-R SXT ST1503f blaCTX-M-15, aph(3")-lb, aph(6)-ld, mdf(A), dfrA1, tet(A), sul2 / I1 (pST16, 90kb), FII, Col156, Col(BS512)  2504 (99.64) 2496 (99.32) cgST64457 
19-0821-3486 2019 45/M Stool Egypt ESC-R SXT ST152 blaCTX-M-15, aadA1, aph(3")-lb, aph(6)-ld, mdf(A), dfrA1,  qnrS1, sul2, tet(A) / FII (F2:A-:B-, 83kb), Col156, Col(BS512) 2500 (99.48) 2493 (99.20) cgST112958 
0401930105 2019 50/M Stool Egypt ESC-R SXT ST152 blaCTX-M-15, aadA1, aph(3")-lb, aph(6)-ld, mdf(A), dfrA1, qnrS1, tet(A), sul2 / FII (F2:A-:B-, 83kb), Col156, Col(BS512) 2502 (99.56) 2496 (99.32) cgST112958 
6904-27 2018 35/M Stool Local ESC-R SXT ST152 blaCTX-M-15, aadA1, aph(3")-lb, aph(6)-ld, mdf(A), dfrA1, qnrS1, tet(A), sul2 / FII (F2:A-:B-, 83kb), Col156, Col(BS512) 2502 (99.56) 2497 (99.36) cgST112958 
19-1125-3493 2019 40/F Stool Unknown ESC-R SXT ST152 blaCTX-M-15, aadA1, aph(3")-lb, aph(6)-ld, mdf(A), dfrA1, qnrS1, tet(A), sul2 / FII (F2:A-:B-, 83kb), Col156, Col(BS512) 2496 (99.32) 2489 (99.04) cgST112958 
19-0820-1561 2019 15/F Stool Nepal ESC-R SXT, CIP, AZT ST152 blaCTX-M-15, aadA5, mdf(A), mph(A), dfrA1, dfrA17, qnrS1, sul1 / FII (F2: A-:B-, 83kb), Col156, Col(BS512) 2493 (99.20) 2477 (98.57) cgST117387 
0401952027 2019 45/M Stool Egypt ESC-R SXT, AZT ST152 blaCTX-M-55, aadA1, aph(3")-lb, aph(6)-ld,  mdf(A), mph(A), dfrA1, sul2, tet(A) / I1, FII (F2:A-:B-, 74kb), Col156, Col(BS512)   2498 (99.40) 2489 (99.04) cgST20888 
09163633 2019 50/M Stool Unknown ESC-R SXT ST152 blaCTX-M-27, aadA1, aph(3")-lb, aph(6)-ld,  mdf(A), dfrA1, sul2, tet(A) / FII (F2:A-:B-, 68kb),  B/O/K/Z, Col156, Col(BS512) 2497 (99.36) 2489 (99.04) cgST67380 
3123885 2019 30/M Stool Israel ESC-R SXT, CIP, AZT ST152 blaCTX-M-134, aph(6)-ld, mdf(A), mph(A), dfrA1, sul2, tet(A) / FII (F35:A-:B-, 69kb),  B/O/K/Z, Col156, Col(BS512)    2489 (99.04) 2480 (98.69) cgST114011 
7103-58 g 2018 10/M Stool Romania ESC-S SXT, CIP, AZT ST152 blaTEM-1B, aadA5, aph(3")-lb, aph(6)-ld, mdf(A), mph(A), erm(B), dfrA1/A17, sul1/2, tet(A) / Col156, Col(BS512) 2489 (99.04) 2482 (98.77) cgST107674 
7103-28  g 2018 50/M Stool Romania ESC-S SXT, CIP, AZT ST152 blaTEM-1B, aadA5, aph(3")-lb, aph(6)-ld,  mdf(A), mph(A), erm(B), dfrA1/A17, sul1/2, tet(A) / Col156, Col(BS512) 2490 (99.08) 2481 (98.73) cgST107674 
6407-57 2017 40/M Stool Local ESC-S SXT, CIP, AZT ST152 blaTEM-1B, aadA5, aph(3")-lb, aph(6)-ld, mdf(A), mph(A), erm(B), dfrA1/A17, sul1/2, tet(A) / l1, Col156, Col(BS512) 2492 (99.16) 2484 (98.85) cgST108068 
6110-62 2016 60/F Stool Brazil ESC-S SXT ST152 blaTEM-1B, aph(3")-lb, aph(6)-ld, mdf(A), dfrA8,  sul2 / FII, Col156, Col(BS512) 2499 (99.44) 2492 (99.16) cgST108083 
6105-15 2016 35/M Stool Egypt ESC-S SXT ST152 aadA1, aph(3")-lb, aph(6)-ld, mdf(A), dfrA1, sul2, tet(A) / FII, Col156, Col(BS512) 2497 (99.36) 2487 (98.97) cgST37499 
6101-40 2016 40/F Stool Western 
Africa 
ESC-S SXT ST152 aadA1, aph(3")-lb, aph(6)-ld,  mdf(A), dfrA1, sul2, tet(A) / FII, Col156, Col(BS512) 2492 (99.16) 2479 (98.65) cgST98334 
6412-75 2017 50/M Blood, 
stool 
India ESC-S CIP ST152 mdf(A), dfrA1 / Col156, Col(BS512) 2495 (99.28) 2487 (98.97) cgST101592 
6502-32 2017 40/F Stool Dominican 
Republic 
ESC-S SXT ST152 aph(3")-lb, aph(6)-ld,  mdf(A), dfrA1, sul2, tet(A) / l1, Col156, Col(BS512) 2494 (99.24) 2484 (98.85) cgST108763 
7111-23 2019 25/F Stool Philippines ESC-S - ST152 sul2, dfrA14, aph(3")-lb, aph(6)-ld, mdf(A) / I1, FII, Col156 2495 (99.28) 2481 (98.73) cgST108909 
7109-28 2019 30/M Stool Colombia ESC-S SXT ST152 aadA1, aph(3")-lb, aph(6)-ld, sul2, mdf(A), dfrA1, qnrB19/B5/B81, tet(A) / I1, Col156 2499 (99.44) 2486 (98.93) cgST109254 
7001-38 2018 50/F Stool Local ESC-S SXT ST152 aadA1, mdf(A), dfrA1 / Col156, Col(BS512) 2503 (99.60) 2494 (99.24) cgST113036 
24 
 
f ST1503 is a single allele variant of ST152 525 
g These two patients are relatives 526 
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LEGEND TO THE FIGURES 527 
Figure 1. BLAST comparisons of S. sonnei blaCTX-M-carrying plasmids against reference 528 
sequences. A) Five S. sonnei blaCTX-M-3-carrying IncI1 plasmids against S. sonnei IncI1 529 
plasmid: pLC1477_18-1 (GenBank: CP035009) reference sequence. B) Five S. sonnei blaCTX-530 
M-15-carrying IncFII (F2:A-:B-) plasmids against K. pneumoniae IncFII (F2:A-:B-) plasmid: 531 
pF93-2_1 (GenBank: CP026158) reference sequence. Rings were constructed using BRIG 532 
(BLAST Ring Image Generator) v0.95 software. Similarities with the reference plasmid are 533 
represented by the colored rings. Genome accession numbers are indicated in the legend. Red 534 
and blue arrows above the rings correspond to gene features of interest. Delta symbol (Δ) next 535 
to feature label corresponds to partial/incomplete gene CDS. For each plasmid, we report 536 
GenBank accession, species of isolation, tree cluster from Fig. 2, year, plasmid name, and 537 
plasmid size.  538 
 539 
Figure 2. Analysis of the core genome phylogeny of 25 S. sonnei isolates together with the 540 
Italian strain LC-1477-18. For each strain, we show: strain, collection year, main β-lactamase 541 
(if present), and cgST. Assembled WGS of strains is presented in a core-genome SNV tree. 542 
The ∆ SNVs value (e.g., ∆=1 SNV) corresponds to the number of non-identical SNVs of the 543 
core-genome between two strains. The four main clusters (grey boxes) were defined when the 544 
nucleotide identity across two or more strains was ≥97.5% of shared SNVs (∆ ≤ 65 SNVs). 545 
The cluster matrix shows the maximum nucleotide identity (%) between all strains across two 546 
clusters (top right corner), and the number of SNVs not shared among all compared strains. 547 
The scale bar (0.05) represents the average number of nucleotide substitutions per site. 548 
Asterisks (*) represent identical cgST as determined by CGE’s cgMLSTFinder (v1.1).  549 
a 
Core-genome represents the maximum total coverage (87%) of the alignment among all 26 550 
S. sonnei conserved sequences, which corresponded to 2’608 SNVs. 551 
b 




Cluster-2: Strains shared 98.01% SNVs 553 
d 
Cluster-3: Strains shared 99.08% SNVs 554 
e 
Cluster-4: Strains shared 97.54% SNVs 555 
f
 In cluster-1 and cluster-2, the blaCTX-M-3 was consistently carried by the same IncI1-pST57 556 
plasmid (see Fig. 1A) 557 
 558 
Figure 3. Enterobase SNV tree dendrogram of the Swiss S. sonnei (n=25), global lineage 559 
(n=114), matching cgST strains (n=16), and the Italian LC-1477-18 as reference. The 560 
combined SNP profiles of all 156 strains mapped to the reference are represented in a 561 
RAxML tree, corresponding to a total of 9’850 SNVs.  562 
Country labels are represented by colored circles (missing country labels correspond to strains 563 
IBESS820 from the Netherlands, Ss046 from China, and 53G from Korea). Holt lineages I, II, 564 
III, GIII, and IV are presented in color boxes. Dashed black braces with lines correspond to 565 
zoom-in sections of the tree where the present study’s strains are clustered. For the Swiss 566 
isolates we show cluster (if any) / ESBL (if any), while for international strains with matching 567 
cgST we show only the ESBL (if any). Among these strains, those detected in 2019 are 568 
indicated with (*). The scale bar represents the average number of nucleotide substitutions per 569 
site. See Tab. S2 for more information regarding the Parsnp SNV analysis results for zoom-in 570 
sections 1-7: 571 
1
 Compared to the Swiss isolates possessing the same cgST, strains 811053, 266979, 175609, 572 
152507, CFSAN091705, and 795376 show 0-1, 0-4, 1-5, 2, 5, and 4 SNVs, respectively  573 
2
 Compared to the Swiss isolate, strain 526163 has the same cgST and shows 2 SNVs 574 
3
 Compared to the Swiss isolates, strain 299890 has the same cgST and shows 2-3 SNVs 575 
4
 Compared to the Swiss isolates possessing the same cgST, strains 190807, 201907857, 576 
638735, IBESS820, 821179, and PNUSAE013040 show 6, 1, 1, 0, 8, and 1 SNVs, 577 




 61 SNVs between the Swiss isolate and the one found in Egypt 579 
6
 Compared to the Swiss isolate, strain 191891 has the same cgST and shows 2 SNVs 580 
7
 Compared to the Swiss isolate, strain 524350 has the same cgST and shows 4 SNVs 581 
CP049178 
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